As the skin-booster market grows, the clinical question is shifting from "what to use" to "how to deliver it." Getting a surface-applied active ingredient to its intended depth comes down to how well you can enhance absorption, and that's where a familiar trade-off gets in the way: push delivery harder and pain follows; ease the pain and delivery weakens. re:H (Curiosis) is a transdermal active-ingredient delivery platform built around the SSCM™ (Selective Smart Control Microneedle System) microneedle system, pairing positive and negative pressure control with microneedles to target exactly that intersection of Low Pain and High Delivery. We sat down with Dr. Hyungeun Cho, Chief Medical Director of Rejuel Clinic Gangnam, who runs re:H alongside a broad lineup of energy-based devices and has integrated it into clinical practice, to ask how he balances pain reduction with delivery efficiency. He walks through how he adjusts depth and tip selection to each patient's skin thickness and pore condition, and how he decides when to combine agents like Rejuran, exosomes, and Juvelook.
#MedicalAestheticNews #reH #RejuelClinicGangnam #DrHyungeunCho
★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=20074

Comments
Post a Comment